Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

2018-06-14
Price :
Published : Jun-2018
No. of Pages : 109
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview 7
3 Products under Development 8
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12
4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies 13
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 13
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 14
5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview 15
5.1 Andramed GmbH Company Overview 15
5.2 Boston Scientific Corp Company Overview 16
5.3 C. R. Bard Inc Company Overview 18
5.4 Cagent Vascular LLC Company Overview 21
5.5 Contego Medical, LLC Company Overview 22
5.6 Hexacath SA Company Overview 24
5.7 Medtronic plc Company Overview 25
5.8 MicroPort Scientific Corp Company Overview 26
5.9 Minnesota Health Solutions Corporation Company Overview 28
5.10 NuVascular Technologies Inc Company Overview 29
5.11 QT Vascular Ltd Company Overview 30
5.12 SurModics Inc Company Overview 31
5.13 Terumo Corp Company Overview 34
5.14 Terumo Europe NV Company Overview 35
6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments 38
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 38
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 40
6.3 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 40
6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 41
6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 41
6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 42
6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 43
6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results 43
6.9 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 46
6.10 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 47
6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 48
6.12 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 50
6.13 Apr 23, 2018: Surmodics Announces FDA Clearance of a New .018" Low-Profile PTA Balloon Dilation Catheter 51
6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 52
6.15 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 52
6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 53
6.17 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 54
6.18 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 56
6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 56
6.20 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 58
6.21 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 59
6.22 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 59
6.23 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 61
6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 63
6.25 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 63
6.26 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 64
6.27 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 66
6.28 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 66
6.29 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 67
6.30 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 68
6.31 Dec 22, 2017: Kaneka releasing a high-pressure balloon catheter to enlarge peripheral vessels 68
6.32 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 69
6.33 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 70
6.34 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 70
6.35 Dec 04, 2017: Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval 72
6.36 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 72
6.37 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 75
6.38 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 76
6.39 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 77
6.40 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 78
6.41 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 80
6.42 Oct 25, 2017: Bard Announces Third Quarter Results 81
6.43 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 83
6.44 Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 84
6.45 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 84
6.46 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 85
6.47 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 86
6.48 Oct 02, 2017: STENTYS: 2017 half-year results 87
6.49 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 88
6.50 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 88
6.51 Sep 18, 2017: Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter 89
6.52 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 90
6.53 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 91
6.54 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 94
6.55 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 94
6.56 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 95
6.57 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 97
6.58 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 97
6.59 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 99
6.60 Jul 24, 2017: Reewarm Gains CFDA Approval 100
6.61 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 101
6.62 Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 101
6.63 Jul 07, 2017: MPSC New COO Glendy Wang on Board 102
6.64 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 102
6.65 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 104
7 Appendix 106
7.1 Methodology 106
7.2 About GlobalData 109
7.3 Contact Us 109
7.4 Disclaimer 109

1.1 List of Tables
Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12
Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development 13
Table 7: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 14
Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Zero-Profile PTA Balloon - Product Status 15
Table 10: Zero-Profile PTA Balloon - Product Description 15
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: Drug Coated Balloon - Below-The-Knee (BTK) - Product Status 16
Table 13: Drug Coated Balloon - Below-The-Knee (BTK) - Product Description 16
Table 14: Next Generation 0.018" Balloon - Product Status 17
Table 15: Next Generation 0.018" Balloon - Product Description 17
Table 16: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 17: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Status 18
Table 18: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Description 18
Table 19: C. R. Bard Inc - Ongoing Clinical Trials Overview 19
Table 20: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions 20
Table 21: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 22: Serranator Bass - Product Status 21
Table 23: Serranator Bass - Product Description 21
Table 24: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 25: PALADIN - Product Status 22
Table 26: PALADIN - Product Description 22
Table 27: Superficial Femoral Artery Balloon - Product Status 23
Table 28: Superficial Femoral Artery Balloon - Product Description 23
Table 29: Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 24
Table 30: MERAK PTA Dilatation Catheter - Product Status 24
Table 31: MERAK PTA Dilatation Catheter - Product Description 24
Table 32: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: Chocolate PTA Balloon Catheter - Product Status 25
Table 34: Chocolate PTA Balloon Catheter - Product Description 25
Table 35: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 36: Reewarm14 - Product Status 26
Table 37: Reewarm14 - Product Description 26
Table 38: Reewarm18 Peripheral Balloon Dilation Catheter - Product Status 27
Table 39: Reewarm18 Peripheral Balloon Dilation Catheter - Product Description 27
Table 40: Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 28
Table 41: Balloon Angioplasty Inflation Device - Product Status 28
Table 42: Balloon Angioplasty Inflation Device - Product Description 28
Table 43: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 44: NuSpun DE Balloon - Product Status 29
Table 45: NuSpun DE Balloon - Product Description 29
Table 46: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
Table 47: Silk PTA Balloon Catheter - Product Status 30
Table 48: Silk PTA Balloon Catheter - Product Description 30
Table 49: SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 50: 0.018" OTW Dual Lumen PTA Catheter - Product Status 31
Table 51: 0.018" OTW Dual Lumen PTA Catheter - Product Description 31
Table 52: 0.018" RX Dual Lumen PTA Catheter - Product Status 32
Table 53: 0.018" RX Dual Lumen PTA Catheter - Product Description 32
Table 54: 0.035" Large Diameter OTW PTA Catheter - Product Status 32
Table 55: 0.035" Large Diameter OTW PTA Catheter - Product Description 33
Table 56: 0.035" Next Generation Workhorse PTA Catheter - Product Status 33
Table 57: 0.035" Next Generation Workhorse PTA Catheter - Product Description 33
Table 58: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 34
Table 59: TRI PTA Balloon - Product Status 34
Table 60: TRI PTA Balloon - Product Description 34
Table 61: Terumo Europe NV Pipeline Products & Ongoing Clinical Trials Overview 35
Table 62: Kanshas Drug Coated Balloon - Product Status 35
Table 63: Kanshas Drug Coated Balloon - Product Description 35
Table 64: Terumo Europe NV - Ongoing Clinical Trials Overview 36
Table 65: Kanshas Drug Coated Balloon - Prospective, Multi-Center, Open, Single Arm Study for the Treatment of Patients Presenting De Novo Lesions in the Superficial Femoral or Popliteal Arteries Using a Kanshas Drug Coated Balloon Catheter 37
Table 66: Glossary 108

1.2 List of Figures
Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development 8
Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory 9
Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path 10
Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date 11
Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials 12
Filed in: Medical Device
Publisher : GlobalData